Boston Scientific (NYSE: BSX) has received United States (U.S.) Food and Drug Administration (FDA) approval and CE Mark for the AngioJet™ ZelanteDVT™ thrombectomy catheter to treat deep vein ...
Boston Scientific Corporation BSX is in the process of conducting a Medical Device Correction of certain AngioJet Ultra Consoles, which were shipped to customers without the required operator’s manual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback